These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15592517)

  • 21. Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2.
    Kamino M; Kishida M; Kibe T; Ikoma K; Iijima M; Hirano H; Tokudome M; Chen L; Koriyama C; Yamada K; Arita K; Kishida S
    Cancer Sci; 2011 Mar; 102(3):540-8. PubMed ID: 21205070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid induced downregulation of MYCN is not mediated through changes in Sp1/Sp3.
    Kanemaru KK; Tuthill MC; Takeuchi KK; Sidell N; Wada RK
    Pediatr Blood Cancer; 2008 Apr; 50(4):806-11. PubMed ID: 17554788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
    Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
    Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt signalling is a bi-directional vulnerability of cancer cells.
    Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
    Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.
    Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ
    Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma.
    Gupta A; Williams BR; Hanash SM; Rawwas J
    Cancer Res; 2006 Aug; 66(16):8100-8. PubMed ID: 16912187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of the growth factor Wnt-5A in human malignancy.
    Iozzo RV; Eichstetter I; Danielson KG
    Cancer Res; 1995 Aug; 55(16):3495-9. PubMed ID: 7627953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
    Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
    Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.
    Nakaguro M; Kiyonari S; Kishida S; Cao D; Murakami-Tonami Y; Ichikawa H; Takeuchi I; Nakamura S; Kadomatsu K
    Cancer Sci; 2015 Mar; 106(3):237-43. PubMed ID: 25557119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
    Shih YY; Lee H; Nakagawara A; Juan HF; Jeng YM; Tsay YG; Lin DT; Hsieh FJ; Pan CY; Hsu WM; Liao YF
    PLoS One; 2011; 6(10):e26236. PubMed ID: 22022577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation.
    Manohar CF; Salwen HR; Furtado MR; Cohn SL
    Tumour Biol; 1996; 17(1):34-47. PubMed ID: 7501971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
    Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
    Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction.
    Villanueva S; Glavic A; Ruiz P; Mayor R
    Dev Biol; 2002 Jan; 241(2):289-301. PubMed ID: 11784112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification.
    Nara K; Kusafuka T; Yoneda A; Oue T; Sangkhathat S; Fukuzawa M
    Int J Oncol; 2007 May; 30(5):1189-96. PubMed ID: 17390021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of MYCN and ID2 overexpression in neuroblastoma.
    Alaminos M; Gerald WL; Cheung NK
    Pediatr Blood Cancer; 2005 Dec; 45(7):909-15. PubMed ID: 16047351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
    Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
    Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology.
    Schwab M
    Ann N Y Acad Sci; 2002 Jun; 963():63-73. PubMed ID: 12095930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.